Pharmaceutical

DDW Editor Reece Armstrong looks ahead to ELRIG Drug Discovery 2022 and why he and the team are excited to attend. It’s no secret that over the past couple of years, tradeshows within the life sciences sector, and indeed in general across the globe, have taken a massive hit. The Covid-19 pandemic all but put […]

Technology company PeakData has raised €12.1 million in Series A funding to support its artificial intelligence (AI) platform.  Launched in 2018, PeakData enables pharmaceutical companies to uncover the whole therapeutic area by mapping the healthcare professionals (HCPs) most relevant to their target market. It’s hoped that this enables patients to benefit from new medicines, faster. […]

DDW’s Reece Armstrong speaks to Scott Gray, President & CEO of Clincierge about its unique approach to improving the clinical trial experience for patients.   For patients participating in a clinical trial, the experience can be one of considerable hardship, both from a perspective on their health and the impact on their everyday lives. Logistically demanding […]

Absolute Antibody has expanded it Prometheus antibody humanisation service to deliver humanised antibodies from a wider range of species than it had previously had.   The company’s Prometheus antibody humanisation service now offers humanisation from -murine origin species, including rabbit antibodies and single-domain camelid nanobodies.  Humanisation is a critical step in the development pathway of all […]

The theme for International Women’s Day 2022 is ‘Break the Bias’, in which society is encouraged to celebrate women’s achievements, in turn raising awareness against bias and inspiring positive action for equality. Though the initiative is interdisciplinary, the drug discovery, life science and pharmaceutical world boasts many achievements of this nature. DDW’s Megan Thomas has […]

The MDI Biological Laboratory (MDIBL) has appointed James Strickland as Director of MDI Bioscience, a new initiative focused on using non-mammalian models in early drug discovery and development.   Background  Strickland brings experience in pharmaceutical development to his new position, in which he will leverage the MDI Biological Laboratory’s 124-year history of using non-mammalian animal […]

A Phase I clinical trial of the world’s first multivariant Covid-19 vaccine has been launched by US pharmaceutical company Gritstone in collaboration with The University of Manchester UK and Manchester University NHS Foundation Trust.  Initially involving participants aged 60+, its creators say the drug, GRT-R910, can boost the immune response of first-generation Covid-19 vaccines to […]

By Naheed Kurji, Co-founder and Executive of the Alliance for Artificial Intelligence in Healthcare (AAIH), CEO of Cyclica; and Andreas Windemuth, Ph.D, Chief Science Officer of Cyclica Over the past decade, a new industry has arisen that seeks to apply artificial intelligence (AI), or more aptly machine learning (ML) technologies, to healthcare. This surge was […]

BlueRock Therapeutics, FUJIFILM Cellular Dynamics and Opsis Therapeutics have entered a strategic research joint venture focused on developing cell therapies for patients with ocular diseases. The companies will combine their collective expertise to discover and develop off-the-shelf iPS cell therapies for ocular diseases. Under this agreement, BlueRock Therapeutics will have the option to exclusively license […]

The Janssen Pharmaceutical Companies of Johnson & Johnson has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) seeking approval of cilta-cel, an investigational B cell maturation antigen (BCMA)-directed chimeric antigen receptor T cell (CAR-T) therapy, for the treatment of patients with relapsed and/or refractory multiple myeloma. The application is supported by […]